Senseonics Stock Down Despite New FDA Approval for Eversense 365 [Yahoo! Finance]
Senseonics Holdings, Inc. (SENS)
Last senseonics holdings, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
senseonics.com/investor-relations
Company Research
Source: Yahoo! Finance
SENS, along with Ascensia Diabetes Care, announced the receipt of the FDA's clearance for the next-generation Eversense 365 continuous glucose monitoring (CGM) system for people with Type 1 and Type 2 diabetes aged 18 years and above. Eversense 365 has been cleared as an integrated CGM (iCGM) system, indicating that it can integrate with compatible medical devices, including insulin pumps, as part of an automated insulin delivery system. Ascensia, a subsidiary of PHC Holdings Corporation, expects to initiate the U.S. launch of Eversense 365 U.S. in the fourth quarter of 2024, with work ongoing to transition coverage availability to facilitate immediate access to as many users as possible. The latest FDA clearance of Senseonics' Eversense 365 is expected to significantly solidify its foothold in the CGM business across the nation. Likely Trend of SENS Stock Following the News Following the announcement on Sept. 17, 2024, shares of the company moved nearly 20% south to $0.35 at
Show less
Read more
Impact Snapshot
Event Time:
SENS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SENS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SENS alerts
High impacting Senseonics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
SENS
News
- Senseonics Holdings, Inc. (NYSE: SENS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Senseonics and Ascensia announce FDA approval for one-year CGM system [Yahoo! Finance]Yahoo! Finance
- FDA Approves Glucose Monitor That Can Be Worn for a Year [Yahoo! Finance]Yahoo! Finance
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGMBusiness Wire
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGMGlobeNewswire
SENS
Earnings
- 8/8/24 - In-Line
SENS
Analyst Actions
- 8/14/24 - HC Wainwright
SENS
Sec Filings
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- 7/3/24 - Form 4
- SENS's page on the SEC website